Trump's NIH has gutted research into the diseases most likely to kill you or someone you love. Here's the damage👇 • 116 cancer research grants terminated or frozen, worth $273 million • 255 fewer new cancer grants funded in 2025 compared to 2024, a 12% decline • Duke lost nearly $20 million for brain cancer treatment research. Brain cancer is the leading cause of cancer-related death in children under 15. • Duke lost a separate $20.8 million grant for next-generation cancer treatments, including tumor vaccines. Terminated. • MD Anderson lost $9 million in ovarian cancer research. Ovarian cancer kills 13,000 American women per year. • The Pediatric Brain Tumor Consortium, 26 years of clinical trials for children with brain tumors, was defunded. Enrollment in ongoing trials has been paused. • A UCLA scientist had his T-cell cancer immunotherapy research suspended. Even after reinstatement, the uncertainty forced him to scale back and prepare to end his work. • 65 Alzheimer's research grants terminated or frozen, worth $94 million • 357 fewer new Alzheimer's grants funded in 2025 compared to 2024, a 33% decline, the steepest of any disease area • 14 of 35 NIH-funded Alzheimer's Disease Research Centers saw approximately $65 million in funding halted • Approximately 1,000 grants worth an estimated $600 million were delayed after the cancellation of National Advisory Council on Aging meetings • A 35-year Johns Hopkins study tracking individuals from childhood to midlife to identify Alzheimer's risk factors was terminated. A generation of irreplaceable data, destroyed. • A Midwestern physician-scientist with 13 years as a principal investigator and over 100 publications saw two major NIH grants end. In their words: "I am very concerned that I will not be able to continue in this line of work." • 72 diabetes research grants terminated or frozen, worth $99 million • 168 fewer new diabetes grants funded in 2025 compared to 2024, a 16% decline • Stanford lost a $2.7 million grant testing whether home food deliveries improved outcomes for diabetes patients. Terminated. • 67 heart disease research grants terminated or frozen, worth $95 million • 183 fewer new heart disease grants funded in 2025 compared to 2024, a 13% decline • Johns Hopkins lost an $18.9 million grant funding strategies to reduce heart health disparities. Terminated.